Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,159.00    20.00 (1.76%)
Bid:
1,159.00
Ask:
1,159.50
Spread: 0.50 (0.043%)
Market Cap: £9.84b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

10 Mar 2016 17:31

RNS Number : 7558R
Smith & Nephew Plc
10 March 2016
 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

 

SMITH & NEPHEW PLC

 

10 March 2016

 

Smith & Nephew plc announces that it has today been informed of the following transactions by Directors and persons discharging managerial responsibilities ("PDMRs") in relation to conditional awards over shares:

 

1. FINAL VESTING ON 7 MARCH 2016 OF 2013 EQUITY INCENTIVE AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2010:

 

Name of Director / PDMR

Number of Ordinary Shares acquired (iii)

Number of Ordinary Shares sold

Total Ordinary Shares / ADS' held following notification

Olivier Bohuon

28,767

(ii) 13,554

416,213 Ordinary Shares

John Campo

9,078

(ii) 4,287

84,922 Ordinary Shares (including 10,545 ADS')

Michael Frazzette

10,186

(ii) 3,859

102,303 Ordinary Shares (including 37,120 ADS')

Elga Lohler

4,177

0

32,679 Ordinary Shares (including 3,015 ADS')

Cyrille Petit

5,419

(ii) 2,556

48,991 Ordinary Shares

 

(i) The awards were granted under the Global Share Plan 2010 on 7 March 2013. One third of the shares vested on 7 March 2014, a further third vested on 7 March 2015 and the final third vested on 7 March 2016.

(ii) Ordinary Shares were sold to cover taxation obligations arising on the vesting of the awards.

(iii) This number includes the dividend equivalent shares which participants receive on vested shares.

 

 

2. PARTIAL VESTING ON 7 MARCH 2016 OF 2014 EQUITY INCENTIVE AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2010:

 

Name of Director / PDMR

Number of Ordinary Shares acquired (iii)

Number of Ordinary Shares sold

Total Ordinary Shares / ADS' held following notification

Olivier Bohuon

21,222

(ii) 10,000

416,213 Ordinary Shares

Julie Brown

9,118

(ii) 4,301

90,040 Ordinary Shares

Rodrigo Bianchi

3,233

0

58,504 Ordinary Shares

John Campo

6,595

(ii) 3,114

84,922 Ordinary Shares (including 10,545 ADS')

Bradley Cannon

3,926

(iv) 2,707

14,390 Ordinary Shares

Michael Frazzette

7,558

(ii) 2,864

102,303 Ordinary Shares (including 37,120 ADS')

Elga Lohler

2,950

0

32,679 Ordinary Shares (including 3,015 ADS')

Cyrille Petit

6,198

(ii) 2,924

48,991 Ordinary Shares

 

(i) The awards were granted under the Global Share Plan 2010 on 7 March 2014. One third of the shares vested on 7 March 2015 and a further third vested on 7 March 2016. The final third will vest on 7 March 2017.

(ii) Ordinary Shares were sold to cover taxation obligations arising on the vesting of the awards.

(iii) This number includes the dividend equivalent shares which participants receive on vested shares.

(iv) Some of the Ordinary Shares were sold to cover taxation obligations arising on the vesting of the awards.

 

3. PARTIAL VESTING ON 9 MARCH 2016 OF 2015 EQUITY INCENTIVE AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2010:

 

Name of Director / PDMR

Number of Ordinary Shares acquired (iii)

Number of Ordinary Shares sold

Total Ordinary Shares / ADS' held following notification

Olivier Bohuon

13,073

(ii) 6,166

416,213 Ordinary Shares

Julie Brown

8,380

(ii) 3,953

90,040 Ordinary Shares

Rodrigo Bianchi

8,041

0

58,504 Ordinary Shares

John Campo

5,518

(ii) 2,606

84,922 Ordinary Shares (including 10,545 ADS')

Bradley Cannon

3,613

(iv)2,491

14,390 Ordinary Shares

Michael Frazzette

6,955

(ii) 2,635

102,303 Ordinary Shares (including 37,120 ADS')

Elga Lohler

3,046

0

32,679 Ordinary Shares (including 3,015 ADS')

Cyrille Petit

5,543

(ii) 2,615

48,991 Ordinary Shares

Glenn Warner

3,315

(ii) 1,187

6,616 Ordinary Shares (including 915 ADS')

 

(i) The awards were granted under the Global Share Plan 2010 on 9 March 2015. One third of the shares vested on 9 March 2016, a further third will vest on 9 March 2017 and the final third will vest on 9 March 2018.

(ii) Ordinary Shares were sold to cover taxation obligations arising on the vesting of the awards.

(iii) This number includes the dividend equivalent shares which participants receive on vested shares.

(iv) Some of the Ordinary Shares were sold to cover taxation obligations arising on the vesting of the awards.

 

 

 

4. VESTING ON 7 MARCH 2016 OF 2013 SMITH & NEPHEW GLOBAL SHARE PLAN (PERFORMANCE SHARE AWARDS):

 

Name of Director / PDMR

Number of Ordinary Shares acquired (iii)

Number of Ordinary Shares sold

Total Ordinary Shares / ADS' held following notification

Olivier Bohuon

84,505

(ii) 39,817

416,213 Ordinary Shares

Julie Brown

46,603

(ii) 21,963

90,040 Ordinary Shares

John Campo

18,245

(ii) 8,607

84,922 Ordinary Shares (including 10,545 ADS')

Bradley Cannon

10,426

(iv)7,188

14,390 Ordinary Shares

Michael Frazzette

20,471

(ii) 7,749

102,303 Ordinary Shares (including 37,120 ADS')

Elga Lohler

6,716

0

32,679 Ordinary Shares (including 3,015 ADS')

Cyrille Petit

16,187

(ii) 7,630

48,991 Ordinary Shares

 

(i) The awards were granted under the Global Share Plan 2010 on 7 March 2013 and as announced on 12 February 2016, vested at 33% of maximum and settled on 7 March 2016.

(ii) Ordinary Shares were sold to cover taxation obligations arising on the vesting of the awards.

(iii) This number includes the dividend equivalent shares which participants receive on vested shares.

(iv) Some of the Ordinary Shares were sold to cover taxation obligations arising on the vesting of the awards.

 

5. VESTING ON 7 MARCH 2016 OF 2013 SMITH & NEPHEW GLOBAL SHARE PLAN CONDITIONAL SHARE AWARD:

 

Name of PDMR

Number of Ordinary Shares acquired

Number of Ordinary Shares sold

Total Ordinary Shares / ADS' held following notification

Bradley Cannon

20,000

(ii) 13,789

14,390 Ordinary Shares

 

(i) The award was granted under the Global Share Plan 2010 on 7 March 2013.

(ii) Some of the Ordinary Shares were sold to cover taxation obligations arising on the vesting of the awards.

 

 

Additional Notes:

 

1. The Ordinary Shares were released and sold in London, UK.

 

2. The market value of Ordinary Shares acquired and sold on 7 March 2016 was 1,136.62p per Ordinary Share. The closing mid-market price on 7 March 2016 was 1138p per Ordinary Share.

 

3. The market value of Ordinary Shares acquired and sold on 9 March 2016 was 1,134p per Ordinary Share. The closing mid-market price on 9 March 2016 was 1130p per Ordinary Share.

 

4. The percentages of issued share capital acquired, disposed and held following notification are all under 0.01% of the total issued share capital of the Company.

 

5. One ADS is the equivalent of two Ordinary Shares of US$0.20 each.

 

 

This announcement is made in accordance with the requirements of DTR 3.1.4 R (1)(a)

 

 

Vickie Reuben

Deputy Company Secretary

Smith & Nephew plc

 

Tel: 020 7401 7646

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFFDVTIILIR
Date   Source Headline
5th Jun 202612:12 pmRNSTransaction in Own Shares
4th Jun 20264:05 pmRNSDirector/PDMR Shareholding
3rd Jun 202611:21 amRNSDirector/PDMR Shareholding
3rd Jun 202610:35 amRNSAdmission to Trading
1st Jun 20263:10 pmRNSTotal Voting Rights
29th May 202610:37 amRNSTransaction in Own Shares
27th May 20269:31 amRNSPre Stabilisation Notice
22nd May 20261:32 pmRNSAdmission to Trading
22nd May 20269:58 amRNSTransaction in Own Shares
20th May 202611:25 amRNSDirector/PDMR Shareholding
19th May 20268:53 amRNSHolding(s) in Company
15th May 202612:28 pmRNSTransaction in Own Shares Replacement
15th May 202611:41 amRNSTransaction in Own Shares
14th May 20269:25 amRNSHolding(s) in Company
12th May 20264:03 pmRNSSterling Amount of Dividend
8th May 20267:00 amRNSShare Buyback Programme
6th May 20262:25 pmRNSResult of AGM
6th May 20267:00 amRNSSmith+Nephew First Quarter 2026 Trading Update
1st May 20261:10 pmRNSTotal Voting Rights
27th Apr 20267:00 amRNSExpert surgeons insights event for investors
22nd Apr 20268:46 amRNSNotice of Results
16th Apr 202611:12 amRNSDirector/PDMR Shareholding
15th Apr 20263:46 pmRNSDirector Declaration
14th Apr 20262:59 pmRNSReplacement: Annual Financial Report & AGM Notice
1st Apr 202612:23 pmRNSTotal Voting Rights
24th Mar 20264:16 pmRNSDirector/PDMR Shareholding
24th Mar 20268:45 amRNSHolding(s) in Company
16th Mar 20263:08 pmRNSAnnual Financial Report & Notice of AGM
16th Mar 20263:08 pmRNSAnnual Financial Report & Notice of AGM
10th Mar 20262:30 pmRNS-RSmith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention
5th Mar 20267:30 amRNSDirector Declaration
2nd Mar 20261:36 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSFinal Results
5th Feb 202611:56 amRNSNotice of Results
2nd Feb 20264:00 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Feb 20263:05 pmRNSTotal Voting Rights
23rd Jan 20262:00 pmRNSDirector/PDMR Shareholding
21st Jan 20264:11 pmRNSCompletion of Acquisition
12th Jan 20264:30 pmRNSAcquisition of Integrity Orthopaedics
2nd Jan 202610:07 amRNSTotal Voting Rights
8th Dec 20257:00 amRNSNew Strategy and 2028 Financial Targets
1st Dec 20254:10 pmRNSTotal Voting Rights
19th Nov 202510:00 amRNSDirector/PDMR Shareholding
18th Nov 202510:18 amRNSHolding(s) in Company
12th Nov 20259:24 amRNSDirector/PDMR Shareholding
11th Nov 20254:40 pmRNSHolding(s) in Company
10th Nov 20251:46 pmRNSDirector/PDMR Shareholding
7th Nov 20259:38 amRNSDirector/PDMR Shareholding
7th Nov 20259:35 amRNSDirector/PDMR Shareholding
6th Nov 20257:01 amRNSDirectorate change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.